University of Queensland Reports Findings in Diabetes Research (Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021): Diabetes Research

Insurance Daily News

2024 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Diabetes Research is the subject of a report. According to news reporting out of Brisbane, Australia, by NewsRx editors, research stated, “This study aims to investigate the trends in treatment coverage through dispensing diabetes medications in Vietnam from 2015 to 2021. The findings will serve to inform health policies to mitigate the health burden of Type 2 diabetes mellitus (T2DM).”

Our news journalists obtained a quote from the research from the University of Queensland, “We collected information on major antidiabetic medicines from General Department of Vietnam Customs and payments for antidiabetics via national health insurance. We applied ordinary least squares models, accounting for economic and health outcome characteristics, to estimate the association between the annual mass of medications and related factors. Nationally, the total mass/doses of all antidiabetic drugs increased rapidly from 2015 to 2021, based on both databases. Metformin was the most frequently prescribed medicine, with the total mass increasing nearly threefold over the study period. Gliclazide, a Sulfonylureas drug, ranked second. In the multivariate regression analysis, a one-unit increase in adults with diabetes (in 1000 s) was associated with 0·11 % (95 %CI = 0.0005; 0.0076) and 0·13 % (95 %CI = 0.0007; 0.0242) higher mass of Metformin and Glimepiride, respectively. Policies changes were related to significant increase of diabetes medication dispenses in Vietnam.”

According to the news editors, the research concluded: “The high treatment coverage indicates impressive progress in achieving universal health coverage in Vietnam, meeting the UN Sustainable Development Goal (SDG).”

This research has been peer-reviewed.

For more information on this research see: Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021. Diabetes Research and Clinical Practice, 2024:111691. Diabetes Research and Clinical Practice can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Diabetes Research and Clinical Practice - http://www.journals.elsevier.com/diabetes-research-and-clinical-practice/)

Our news journalists report that additional information may be obtained by contacting Anh Kim Dang, Queensland Alliance for Environmental Health Sciences (QAEHS), University of Queensland, 20 Corn-wall Street, Woolloongabba 4102, Brisbane, Australia. Additional authors for this research include Binh Ngan Vu, Toi Phung Lam, Thanh Kim Thi Ho, Anh Kieu Thi Nguyen, Huong Thi Le, Abdullah A. Mamun, Dung Phung and Phong K. Thai.

Publisher contact information for the journal Diabetes Research and Clinical Practice is: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland.